A prospective, randomized, double blind, placebo controlled, study of orally administered ZYG19 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics in volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2016
At a glance
- Drugs ZYG 19 (Primary)
- Indications Diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
- 21 Jan 2012 New trial record